62 related articles for article (PubMed ID: 11351312)
1. A prospective study of insulin-like growth factor-I, IGF-binding proteins-1, -2 and -3 and lung cancer risk in women.
Lukanova A; Toniolo P; Akhmedkhanov A; Biessy C; Haley NJ; Shore RE; Riboli E; Rinaldi S; Kaaks R
Int J Cancer; 2001 Jun; 92(6):888-92. PubMed ID: 11351312
[TBL] [Abstract][Full Text] [Related]
2. Circulating insulin-like growth factors and risks of overall, aggressive and early-onset prostate cancer: a collaborative analysis of 20 prospective studies and Mendelian randomization analysis.
Watts EL; Perez-Cornago A; Fensom GK; Smith-Byrne K; Noor U; Andrews CD; Gunter MJ; Holmes MV; Martin RM; Tsilidis KK; Albanes D; Barricarte A; Bueno-de-Mesquita HB; Cohn BA; Deschasaux-Tanguy M; Dimou NL; Ferrucci L; Flicker L; Freedman ND; Giles GG; Giovannucci EL; Haiman CA; Hankey GJ; Holly JMP; Huang J; Huang WY; Hurwitz LM; Kaaks R; Kubo T; Le Marchand L; MacInnis RJ; Männistö S; Metter EJ; Mikami K; Mucci LA; Olsen AW; Ozasa K; Palli D; Penney KL; Platz EA; Pollak MN; Roobol MJ; Schaefer CA; Schenk JM; Stattin P; Tamakoshi A; Thysell E; Tsai CJ; Touvier M; Van Den Eeden SK; Weiderpass E; Weinstein SJ; Wilkens LR; Yeap BB; ; Allen NE; Key TJ; Travis RC
Int J Epidemiol; 2023 Feb; 52(1):71-86. PubMed ID: 35726641
[TBL] [Abstract][Full Text] [Related]
3. Influence of insulin-like growth factor binding protein (IGFBP)-1 and IGFBP-3 on bone health: results from the European Male Ageing Study.
Pye SR; Almusalam B; Boonen S; Vanderschueren D; Borghs H; Gielen E; Adams JE; Ward KA; Bartfai G; Casanueva FF; Finn JD; Forti G; Giwercman A; Han TS; Huhtaniemi IT; Kula K; Labrie F; Lean ME; Pendleton N; Punab M; Silman AJ; Wu FC; O'Neill TW;
Calcif Tissue Int; 2011 Jun; 88(6):503-10. PubMed ID: 21503646
[TBL] [Abstract][Full Text] [Related]
4. Insulin-like growth factors and risk of kidney cancer in men.
Major JM; Pollak MN; Snyder K; Virtamo J; Albanes D
Br J Cancer; 2010 Jun; 103(1):132-5. PubMed ID: 20517306
[TBL] [Abstract][Full Text] [Related]
5. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition.
Lin C; Travis RC; Appleby PN; Tipper S; Weiderpass E; Chang-Claude J; Gram IT; Kaaks R; Kiemeney LA; Ljungberg B; Tumino R; Tjønneland A; Roswall N; Overvad K; Boutron-Ruault MC; Manciniveri FR; Severi G; Trichopoulou A; Masala G; Sacerdote C; Agnoli C; Panico S; Bueno-de-Mesquita B; Peeters PH; Salamanca-Fernández E; Chirlaque MD; Ardanaz E; Dorronsoro M; Menéndez V; Luján-Barroso L; Liedberg F; Freisling H; Gunter M; Aune D; Cross AJ; Riboli E; Key TJ; Perez-Cornago A
Int J Cancer; 2018 Nov; 143(10):2351-2358. PubMed ID: 29971779
[TBL] [Abstract][Full Text] [Related]
6. Prediagnostic circulating concentrations of plasma insulin-like growth factor-I and risk of lymphoma in the European Prospective Investigation into Cancer and Nutrition.
Perez-Cornago A; Appleby PN; Tipper S; Key TJ; Allen NE; Nieters A; Vermeulen R; Roulland S; Casabonne D; Kaaks R; Fortner RT; Boeing H; Trichopoulou A; La Vecchia C; Klinaki E; Hansen L; Tjønneland A; Bonnet F; Fagherazzi G; Boutron-Ruault MC; Pala V; Masala G; Sacerdote C; Peeters PH; Bueno-de-Mesquita HB; Weiderpass E; Dorronsoro M; Quirós JR; Barricarte A; Gavrila D; Agudo A; Borgquist S; Rosendahl AH; Melin B; Wareham N; Khaw KT; Gunter M; Riboli E; Vineis P; Travis RC
Int J Cancer; 2017 Mar; 140(5):1111-1118. PubMed ID: 27870006
[TBL] [Abstract][Full Text] [Related]
7. Linking Physical Activity to Breast Cancer Risk via the Insulin/Insulin-like Growth Factor Signaling System, Part 2: The Effect of Insulin/Insulin-like Growth Factor Signaling on Breast Cancer Risk.
Drummond AE; Swain CTV; Milne RL; English DR; Brown KA; Skinner TL; Lay J; van Roekel EH; Moore MM; Gaunt TR; Martin RM; Lewis SJ; Lynch BM
Cancer Epidemiol Biomarkers Prev; 2022 Dec; 31(12):2116-2125. PubMed ID: 36464995
[TBL] [Abstract][Full Text] [Related]
8. The blood proteome of imminent lung cancer diagnosis.
Lung Cancer Cohort Consortium (LC3)
Nat Commun; 2023 Jun; 14(1):3042. PubMed ID: 37264016
[TBL] [Abstract][Full Text] [Related]
9. Association between IGFBP1 expression and cancer risk: A systematic review and meta-analysis.
Zhang B; Hong CQ; Lin YW; Luo Y; Ding TY; Xu YW; Peng YH; Wu FC
Heliyon; 2023 Jun; 9(6):e16470. PubMed ID: 37251476
[TBL] [Abstract][Full Text] [Related]
10. A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma.
Liu L; Liu J; Deng X; Tu L; Zhao Z; Xie C; Yang L
BMC Cancer; 2022 Jun; 22(1):715. PubMed ID: 35768804
[TBL] [Abstract][Full Text] [Related]
11. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer.
Pohlman AW; Moudgalya H; Jordano L; Lobato GC; Gerard D; Liptay MJ; Seder CW; Borgia JA
Oncotarget; 2022; 13():393-407. PubMed ID: 35198099
[TBL] [Abstract][Full Text] [Related]
12. IGFBP-1 in cancer: expression, molecular mechanisms, and potential clinical implications.
Lin YW; Weng XF; Huang BL; Guo HP; Xu YW; Peng YH
Am J Transl Res; 2021; 13(3):813-832. PubMed ID: 33841624
[TBL] [Abstract][Full Text] [Related]
13. Serum IGFBP-1 as a potential biomarker for diagnosis of early-stage upper gastrointestinal tumour.
Xu YW; Chen H; Hong CQ; Chu LY; Yang SH; Huang LS; Guo H; Chen LY; Liu CT; Huang XY; Lin LH; Chen SL; Wu ZY; Peng YH; Xu LY; Li EM
EBioMedicine; 2020 Jan; 51():102566. PubMed ID: 31901863
[TBL] [Abstract][Full Text] [Related]
14. Associations between body mass index and the risk of mortality from lung cancer: A dose-response PRISMA-compliant meta-analysis of prospective cohort studies.
Shen N; Fu P; Cui B; Bu CY; Bi JW
Medicine (Baltimore); 2017 Aug; 96(34):e7721. PubMed ID: 28834876
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for IGF-1 in the development of second primary cancers?
Shanmugalingam T; Bosco C; Ridley AJ; Van Hemelrijck M
Cancer Med; 2016 Nov; 5(11):3353-3367. PubMed ID: 27734632
[TBL] [Abstract][Full Text] [Related]
16. The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells.
Boo HJ; Min HY; Jang HJ; Yun HJ; Smith JK; Jin Q; Lee HJ; Liu D; Kweon HS; Behrens C; Lee JJ; Wistuba II; Lee E; Hong WK; Lee HY
Nat Commun; 2016 Sep; 7():12961. PubMed ID: 27666821
[TBL] [Abstract][Full Text] [Related]
17. MicroRNAs-491-5p suppresses cell proliferation and invasion by inhibiting IGF2BP1 in non-small cell lung cancer.
Gong F; Ren P; Zhang Y; Jiang J; Zhang H
Am J Transl Res; 2016; 8(2):485-95. PubMed ID: 27158341
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer.
Kim JS; Kim ES; Liu D; Lee JJ; Solis L; Behrens C; Lippman SM; Hong WK; Wistuba II; Lee HY
Clin Lung Cancer; 2014 May; 15(3):213-21. PubMed ID: 24485233
[TBL] [Abstract][Full Text] [Related]
19. Association of preoperative serum IGF- I concentration with clinicopathological parameters in patients with non-small cell lung cancer.
Fu SL; Tang HX; Liao YD; Jiang WY; Xu QZ; Deng Y; Fu XN
J Huazhong Univ Sci Technolog Med Sci; 2013 Apr; 33(2):224-227. PubMed ID: 23592134
[TBL] [Abstract][Full Text] [Related]
20. Association between circulating levels of IGF-1 and IGFBP-3 and lung cancer risk: a meta-analysis.
Cao H; Wang G; Meng L; Shen H; Feng Z; Liu Q; Du J
PLoS One; 2012; 7(11):e49884. PubMed ID: 23185474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
